drugset / Trial / NCT07416110
Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate immunogenicity consistency between three consecutive batches of commercial-scale productions for Sinovac Rabies vaccine
Timeline
- Start
- 2026-03-04
- Primary completion
- 2026-09-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sinovac rabies vaccine | Vaccine | — | — |
Indications
No indication recorded.